Prevalence of B12 deficiency among patients with type 2 diabetes mellitus using Metformin in Sulaimani governorate /Kurdistan region of Iraq

Govar Othman  Abubakr; Kawa Muhamadamin  Hasan; Hisham  Al-Rawy; Sarbast Fakhradin  Hamid

doi:10.56056/amj.2020.115

Authors

Govar Othman Abubakr MBChB, KHCMS board candidate/ Clinical Hematology, Hiwa Hospital.
Kawa Muhamadamin Hasan MBChB, MD, FRCP, Internal Medicine/ Clinical Hemtology, Hawler Medical University
Hisham Al-Rawy MBChB, FIBMS, Laboratory Hematologist, Sulaimani University/ Faculty of Medicine.
Sarbast Fakhradin Hamid MBChB, MRCP, FRCP, Internal Medicine, Sulaimani University/ Faculty of Medicine.

DOI:

https://doi.org/10.56056/amj.2020.115

Keywords:

Metformin,Peripheral neuropathy, Type 2 diabetes mellitus, Vitamin B12 deficiency

Abstract

Background and objectives:Vitamin B12 deficiency is prevalent among patients with type 2 diabetes mellitus, es- pecially those using Metformin for a long period of time. The aim of this study was to determine the association and prevalence of vitamin B12 deficiency among Kurdish patients with type 2 diabetes mellitus on metformin therapy and its associated clinical complications.

Methods: This cross-sectional study was conducted in the Diabetes and Endocrine Center of Sulaimani city. Data, including past medical history, medication history and blood samples, were collected from 223 participants to measure fasting blood sugar, blood cells counts, HbA1c, renal function and serum B12 level.

Results: This study found a high prevalence of vitamin B12 deficiency, 24.6% in patients with type 2 dia- betes mellitus on Metformin therapy. There was a significant difference between mean B12 levels of those with B12 deficiency (145.24 ± 32.88 pg/ml) and those with normal serum B12 level (387.62 ±281.44 pg/ml). No relationship existed between vitamin B12 levels and the dose and duration of metformin use. However, there was a statically significant relationship between serum vitamin B12 and peripheral neuropathy.

Conclusions: Prevalence of vitamin B12 deficiency among patients using Metformin is high, but there is no significant effect of the dose and duration of Metformin exposure on B12 concentration. Additionally, there’s a significant relationship between the presence of neuropathy and B12 level.

Downloads

Download data is not yet available.

References

Gojka Roglic, Cherian Varghese, Leanne Riley, Alison Harvey. Global report on diabetes WHO. 2016; 25.

Kirpichnikou D, Mcfarlane S, Sowers JR. Metformin: an update. Ann Intern Med 2002. 137;25-33.

Inzucchi SE, Bergenstal RM, Buse JB. American Diabetes Association (ADA). European Association for the Study of Diabetes (EASD). Manage- ment of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35:1364–79.

Liu KW, Dai LK, Jean W. Metformin related vitamin B12 deficiency. Age and Ageing 2006; 35(2): 200-01.

Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009; 25: 1150-6.

de Jager J, Kooy A, Lehert P et al. Longterm treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ 2010; 340:c2181.

Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000; 23(9):1227–31.

Wile DJ, Toth C. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy; Diabetes Care. 2010; 33: 156–61.

Hemmer B, Glocker FX, Schumacher M. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 1998; 65:822.

Kumar S. Vitamin B12 deficiency presenting with an acute reversible extrapyramidal syndrome. Neurol India 2004; 52:507.

Berchtold P, Bolli P, Arbenz U, Keiser G. Disturbance of intestinal absorption following metformin therapy (observations on the mode of action of biguanides). Diabetologia. 1969; 5:405–12.

Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Topolski R. The prevalence of vitamin B12 deficiency in patients with type 2 diabetes, a cross sectional study. J Am Board Fam Med. 2009; 22(5):528-34.

Iftikhar R, Kamran SM, Qadir A, Iqbal Z, bin Usman H. Prevalence of Vitamin B12 deficiency in patients of type 2 diabetes mellitus on metformin: A case control study from Pakistan. Pan Afr Med J. 2013; 16: 67.

Akabwai GP, Kibirige D, Mugenyi L. Vitamin B12 deficiency among adult diabetic patients in Uganda: relation to glycaemic control and hae- moglobin concentration. J Diabetes Metab Disord. 2016; 15: 26.

Marar O, Senturk S, Agha A, Thompson C, Smith D. Prevalence of Vitamin B12 deficiency in patients with type 2 diabetes mellitus on met-formin. Royal Coll Surg Ireland Student Med J. 2011; 4(1):16-20.

Ahmed M, Muntingh G, Rheeder P. Vitamin B12 deficiency in met- formin treated type-2 diabetes patients, prevalence and association with peripheral neuropathy. BMC Pharmacology and Toxicology.2016; 17(1):44.

Beulens JW, Hart HE, Kuijs R, Kooijman-Buiting AM, Rutten GE. Influ- ence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015; 52(1):47–53.

Nervo M, Lubini A, Raimundo FV et al. Vitamin B12 in metformin treated diabetic patients, a cross-sectional study in Brazil. Rev Assoc Med Bras. 2011; 57(1):46-9.

Hvas AM, Nexo E. Diagnosis and treatment of vitamin B12 deficien- cyan update. Haematologica. 2006; 91(11):1506-12.

Obeid R, Jung J, Falk J, et al. Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes. Biochimie. 2013; 95:1056–61.

Yetley E., Pfeiffer C., Phinney K.et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary. Am J Clin Nutr.2011; 94(1); 313S–321S.

Wulffele MG, Kooy A, Lehert P, et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebocon trolled trial. J Intern Med. 2003; 254(5):455-63.

Liu Q , Li S, Quan H, Li J. Vitamin B12 status in metformin treated patients: systematic review. PLoS One 2014; 9: e100379.

Aroda V., Edelstein S., Goldberg R et al. The Diabetes Prevention Program Research Group. Long term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study J Clin Endocrinol Metab.2016; 101(4); 1754–61.

Todd J, Florez J. An update on the pharmacogenomics of metform- in: progress, problems and potential: Pharmacogenomics. 2014;15(4): 529–39.

Melemedjian OK, Khoutorsky A, Sorge RE et al. mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK. Pain. 2013;154(7):1080–91.